Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes

Drug Metabolism and Disposition

Volumn 35, Issue 11, 2007, Pages 2023-2034

  Minh, Hien Pham ^a,c   Auzeil, Nicolas ^b   Regazzetti, Anne ^b   Dauzonne, Daniel ^a   Dugay, Annabelle ^b   Menet, Marie Claude ^b   Scherman, Daniel ^a,d   Chabot, Guy G ^a,e  

^a CNRS   (France)

^b Laboratoire de Chimie Analytique   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Ecole Nationale Superieure de Chimie de Lille   (France)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; EPOXIDE HYDROLASE; MITOFLAXONE; OXYGEN; PHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

EID: 35548940757     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.017012     Document Type: Article

References (40)

1. Bauvois B, Puiffe ML, Bongui JB, Paillat S, Monneret C, and Dauzonne D (2003) Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13. J Med Chem 46:3900-3913.
2. Bibby MC, Double JA, and Loadman PM (1988) Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). Br J Cancer 58:341-344.
3. Bibby MC, Double JA, Loadman PM, and Duke CV (1989) Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J Natl Cancer Inst 81:216-220.
4. Bissery MC, Valeriote FA, Chabot GG, Crissman JD, Yost C, and Corbett TH (1988) Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. Cancer Res 48:1279-1285.
5. Breinholt VM, Offord EA, Brouwer C, Nielsen SE, Brosen K, and Friedberg T (2002) In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol 40:609-616.
6. Briet P, Berthelon JJ, and Collonges F (1989) Substituted flavonoid compounds, their salts, their manufacture and medicines containing these materials. European Patent Number EP0341104, 1-106. 1989 Nov 8.
7. Capolongo LS, Balconi G, Ubezio P, Giavazzi R, Taraboletti G, Regonesi A, Yoder OC, and D'Incalci M (1987) Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent. Eur J Cancer Clin Oncol 23:1529-1535.
8. Chabot GG, Bissery MC, and Gouyette A (1989) Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro. Cancer Chemother Pharmacol 24:273-276.
9. Chabot GG and Gouyette A (1991) Reactivity of flavone acetic acid and its acyl glucuronide. Biochem Pharmacol 42:1145-1148.
10. Coombs MM, Bhatt TS, and Vose CW (1981) Microsomal metabolites of the aryl hydrocarbon hydroxylase and tumour inhibitor 7,8-benzoflavone. Carcinogenesis 2:135-140.
11. Corbett TH, Bissery MC, Wozniak A, Plowman J, Polin L, Tapazoglou E, Dieckman J, and Valeriote F (1986) Activity of flavone acetic acid (NSC-347512) against solid tumors of mice. Invest New Drugs 4:207-220.
12. Cummings J, Double JA, Bibby MC, Farmer P, Evans S, Kerr DJ, Kaye SB, and Smyth JF (1989) Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice. Cancer Res 49:3587-3593.
13. Dauzonne D, Folleas B, Martinez L, and Chabot GG (1997) Synthesis and in vitro cytotoxicity of a series of 3-aminoflavones. Eur J Med Chem 32:71-82.
14. Dauzonne D and Demerseman P (1990) A convenient synthesis of 3-chloro-3,4-dihydro-4-hydroxy-3-nitro-2-phenyl-2H-1-benzopyrans. Synthesis 1990:66-70.
15. de Forni M, Chabot GG, Armand JP, Gouyette A, Klink-Alak M, and Recondo G (1995) Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization. Cancer Chemother Pharmacol 35:219-224.
16. Drewinko B and Yang LY (1986) The activity of flavone acetic acid (NSC 347512) on human colon cancer cells in vitro. Invest New Drugs 4:289-293.
17. Easterbrook J, Fackett D, and Li AP (2001) A comparison of Aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4′-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6β-hydroxylation. Chem Biol Interact 134: 243-249.
18. Evelhoch JL, Bissery MC, Chabot GG, Simpson NE, McCoy CL, Heilbrun LK, and Corbett TH (1988) Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 48:4749-4755.
19. Giavazzi R, Garofalo A, Damia G, Garattini S, and D'Incalci M (1988) Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. Br J Cancer 57:277-280.
20. Guengerich FP (2003) Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch Biochem Biophys 409:59-71.
21. Hill S, Williams KB, and Denekamp J (1989) Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. Eur J Cancer Clin Oncol 25:1419-1424.
22. Hornung RL, Back TC, Zaharko DS, Urba WJ, Longo DL, and Wiltrout RH (1988) Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2. J Immunol 141:3671- 3679.
23. Kerr DJ, Maughan T, Newlands E, Rustin G, Bleehen NM, Lewis C, and Kaye SB (1989) Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. Br J Cancer 60:104-106.
24. Lindsay CK, Gomez DE, and Thorgeirsson UP (1996) Effect of flavone acetic acid on endothelial cell proliferation: evidence for antiangiogenic properties. Anticancer Res 16:425-431.
25. López-Lázaro M (2002) Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anticancer Agents 2:691-714.
26. Mabry TJ, Markham KR, and Thomas MB (1970) Structure analysis of flavonoids by ultraviolet spectroscopy, in The Systematic Identification of Flavonoids pp 35-230, Springer-Verlag, New York.
27. Meng LH, Shankavaram U, Chen C, Agama K, Fu HQ, Gonzalez FJ, Weinstein J, and Pommier Y (2006) Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone γ-H2AX. Cancer Res 66: 9656-9664.
28. Middleton E Jr, Kandaswami C, and Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751.
29. Nielsen SE, Breinholt V, Justesen U, Cornett C, and Dragsted LO (1998) In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 28:389-401.
30. Nikolic D and Van Breemen RB (2004) New metabolic pathways for flavanones catalyzed by rat liver microsomes. Drug Metab Dispos 32:387-397.
31. Oesch F, Herrero ME, Lohmann M, Hengstler JG, and Arand M (2001) Sequestration of biological reactive intermediates by trapping as covalent enzyme-intermediate complex, in Biological reactive intermediates VI - Chemical and Biological Mechanisms in Susceptibility to and Prevention of Environmental Diseases (Dansette PM, Snyder R, Delaforge M, Gibson GG, Greim H, Jollow DJ, Monks TJ, Sipes IG eds) pp 577-586, Kluwer Academic/Plenum Publishers, New York.
32. Plowman J, Narayanan VL, Dykes D, Szarvasi E, Briet P, Yoder OC, and Paull KD (1986) Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Cancer Treat Rep 70:631-635.
33. Pratesi G, Manzotti C, Damia G, and D'Incalci M (1988) Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512). Br J Cancer 58:144-146.
34. Schroyens WA, Dodion PF, Sanders C, Loos M, Dethier NE, Delforge AR, Stryckmans PA, and Kenis Y (1987) In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015). Eur J Cancer Clin Oncol 23:1135-1139.
35. Vyas KP, Shibata T, Highet RJ, Yeh HJ, Thomas PE, Ryan DE, Levin W, and Jerina DM (1983) Metabolism of α-naphthoflavone and β-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems. J Biol Chem 258:5649-5659.
36. Weiss RB, Greene RF, Knight RD, Collins JM, Pelosi JJ, Sulkes A, and Curt GA (1988) Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res 48:5878-5882.
37. Williamson G, Barron D, Shimoi K, and Terao J (2005) In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 39:457-469.
38. Wu W, Liu Z, Song F, and Liu S (2004) Structural analysis of selected characteristic flavones by electrospray tandem mass spectrometry. Anal Sci 20:1103-1105.
39. Xue W and Warshawsky D (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73-93.
40. Zwi LJ, Baguley BC, Gavin JB, and Wilson WR (1989) Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. J Natl Cancer Inst 81:1005-1013.